Medicare's decision to deny coverage for the first new Alzheimer's treatment the FDA has approved in nearly 20 years will ...
Drugs made from antibodies are huge money-makers for some conditions — but they have gained little traction in infectious ...
Vantage Market Research’s recent analysis of the Global Monoclonal Antibodies Market finds that increasing incidence of cancer & other chronic diseases, rising Research and Development (R&D) ...
Researchers sought to determine whether SB12 would be a clinical equivalent to eculizumab for improving lactate dehydrogenase ...
David L. Bartlett, MD, discussed the adoption of key immunotherapies and how exploration of the tumor microenvironment and ...
With terrifying certainty Dr. Eric Hurowitz knew he was especially vulnerable to COVID-19. Even after four vaccines, blood ...
Cambridge-based Spirea, created to advance a new generation of antibody drug conjugate (ADC) therapeutics, has secured ...
13 Enhertu is an antibody-drug ... monoclonal antibodies by linking them to cell-killing agents. In other words, ADCs are antibodies attached to chemotherapy. The combination provides greater ...
Closed System Drug Transfer Device Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR),"Closed System Drug Transfer ...
ROCKVILLE, Md., US, 25 June 2022) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage ...
Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™ IMC-I109V ...
Xentria Inc., a biotech company focused on developing novel biologics to address unmet clinical needs, presented its first set of data showing its novel biologic, XTMAB-16, has the potential to reduce ...